Tandem Health, a Stockholm-based healthtech company, has raised €86.49 million ($100 million) in Series B funding for its AI medical assistant for European clinics. The round was led by the Scaleup Europe Fund, managed by EQT.
Existing investors Kinnevik, Northzone, Amino Collective and Visionaries also participated. Tandem Health announced a €42.6 million Series A round in June 2025. With the new round, the company has raised €138.38 million ($160 million) in total, according to the source report.
The new capital supports Tandem Health's work on AI tools for clinical documentation and care workflows. The Series B is the current funding event; the earlier Series A and cumulative funding figures provide context for it.
